RNA-seq Reveals the Overexpression of IGSF9 in Endometrial Cancer

Figure 8

IGSF9 expression in TCGA endometrial cancer project. (a) Normalized RNA-seq data for IGSF9, transcripts per million (TMP), clinical data of 546 patients cancer specimen versus 35 normal tissues ( value < 0.001). (b) comparison of 23 patients with RNA-seq data from both cancer tissue and normal control ( value < 0.001). (c) Kaplan-Meier survival analysis of 543 patients with IGSF9 expression and outcome data. Log-rank test, value = 0.017.

(a)

(b)

(c)